Molecular Screening for Cancer Treatment Optimization

Clinical trial NCT01566019 · UNKNOWN

Trial details

NCT number: NCT01566019
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Solid Tumors (Any Localization)

Start date: 2011-10-28
Primary completion: 2020-10-01
Enrollment: 2150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.